Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sequencing of Taxanes and New Androgen-targeted Therapies in Metastatic Castration-resistant Prostate Cancer: Results of the International Multicentre Retrospective CATS Database.
Delanoy N, Hardy-Bessard AC, Efstathiou E, Le Moulec S, Basso U, Birtle A, Thomson A, Krainer M, Guillot A, De Giorgi U, Hasbini A, Daugaard G, Bahl A, Chowdhury S, Caffo O, Beuzeboc P, Spaeth D, Eymard JC, Fléchon A, Alexandre J, Helissey C, Butt M, Priou F, Lechevallier É, Deville JL, Goupil MG, Morales R, Thiery-Vuillemin A, Gavrikova T, Barthelemy P, Sella A, Fizazi K, Baciarello G, Fererro JM, Laguerre B, Verret B, Hans S, Oudard S. Delanoy N, et al. Among authors: flechon a. Eur Urol Oncol. 2018 Dec;1(6):467-475. doi: 10.1016/j.euo.2018.05.009. Epub 2018 Jun 8. Eur Urol Oncol. 2018. PMID: 31158090 Clinical Trial.
Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group.
Fizazi K, Tjulandin S, Salvioni R, Germà-Lluch JR, Bouzy J, Ragan D, Bokemeyer C, Gerl A, Fléchon A, de Bono JS, Stenning S, Horwich A, Pont J, Albers P, De Giorgi U, Bower M, Bulanov A, Pizzocaro G, Aparicio J, Nichols CR, Théodore C, Hartmann JT, Schmoll HJ, Kaye SB, Culine S, Droz JP, Mahé C. Fizazi K, et al. Among authors: flechon a. J Clin Oncol. 2001 May 15;19(10):2647-57. doi: 10.1200/JCO.2001.19.10.2647. J Clin Oncol. 2001. PMID: 11352956
Prostate cancer: management of advanced disease.
Droz JP, Fléchon A, Terret C. Droz JP, et al. Among authors: flechon a. Ann Oncol. 2002;13 Suppl 4:89-94. doi: 10.1093/annonc/mdf644. Ann Oncol. 2002. PMID: 12401672 Free article. Review. No abstract available.
[Metastatic prostate cancer].
Droz JP, Flechon A, Terret C. Droz JP, et al. Among authors: flechon a. Rev Prat. 2003 Dec 31;53(20):2258-62. Rev Prat. 2003. PMID: 15018080 French.
Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study.
Fizazi K, Oldenburg J, Dunant A, Chen I, Salvioni R, Hartmann JT, De Santis M, Daugaard G, Flechon A, de Giorgi U, Tjulandin S, Schmoll HJ, Bouzy J, Fossa SD, Fromont G. Fizazi K, et al. Among authors: flechon a. Ann Oncol. 2008 Feb;19(2):259-64. doi: 10.1093/annonc/mdm472. Epub 2007 Nov 27. Ann Oncol. 2008. PMID: 18042838 Free article.
234 results